Is Kingstone Cos., Inc. overvalued or undervalued?

As of 14 November 2025, the valuation grade for Kingstone Cos., Inc. has moved from attractive to fair, indicating a shift in its perceived value. The company appears to be overvalued based on its current metrics, particularly with a P/E ratio of 11, a Price to Book Value of 2.87, and an EV to EBITDA of 76.30, which are significantly higher than its peers like GoHealth, Inc. with a P/E of 2.12 and an EV to EBITDA of 0.42.
In comparison to the S&P 500, Kingstone has shown a strong performance over the 3-year period with a return of 768.28%, but it has underperformed year-to-date with a return of -5.40% compared to the S&P 500's 14.49%. Overall, the combination of the valuation metrics and peer comparisons suggests that Kingstone Cos., Inc. is currently overvalued.